Mammalian models

There are 4 papers on aging in Mammalian models: none in people yet, 4 reviews.

Organism

4 papers study it3 findings

1 new paper in 30 daysSee all 4 papers on Mammalian models

Interventions

2

FOXO4-DRI

upcognitive function1downsenescent cell accumulation1

1 study
  1. FOXO4-DRI decreases senescent cell accumulation in M. models.

    “In aged mammalian models, administering FOXO4-DRI decreases the accumulation of senescent cells”

    Reviewbrain

    Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline

    Naunyn-Schmiedeberg's archives of pharmacology

  2. FOXO4-DRI improves cognitive function in M. models.

    “administering FOXO4-DRI decreases the accumulation of senescent cells, restores cerebral blood flow and the integrity of the blood-brain barrier (BBB), reverses hippocampal atrophy, and enhances cognitive function.”

    Reviewbrain

    Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline

    Naunyn-Schmiedeberg's archives of pharmacology

More on FOXO4-DRI

Polycaprolactone

upfollicle survival1

1 study
  1. Polycaprolactone improves follicle survival in M. models.

    “particularly electrospun poly(ε-caprolactone), offer superior control over architecture, reproducibility and scalability, supporting follicle survival across multiple mammalian models.”

    Reviewelectrospun scaffoldovarian follicle

    Scaffold-based biomaterials in ovarian tissue engineering

    RSC advances

More on Polycaprolactone

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 12 papers in 12 months